Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- 1 November 2002
- journal article
- review article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 119 (5), 992-1007
- https://doi.org/10.1046/j.1523-1747.2002.00613.x
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activitiesLife Sciences, 2001
- Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cellsLife Sciences, 2000
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- Selective-Inhibition of Steroid 5 α-Reductase Isozymes by Tea Epicatechin-3-Gallate and Epigallocatechin-3-GallateBiochemical and Biophysical Research Communications, 1995
- Mechanism of action of androgen in hair folliclesJournal of Dermatological Science, 1994
- Serum androstanediol glucuronide in women with facial hirsutismJournal of the American Academy of Dermatology, 1992
- Periodate-oxidized NADP+ is a powerful inhibitor of human placental estradiol-17 β dehydrogenaseBiochemical and Biophysical Research Communications, 1987
- Inactivation of soluble 17β-hydroxysteroid dehydrogenase of human placenta by fatty acidsJournal of Steroid Biochemistry, 1985
- Tissue production of androgens in women with acneJournal of the American Academy of Dermatology, 1985
- Biochemical and biological studies with 4-aza-steroidal 5α-reductase inhibitorsJournal of Steroid Biochemistry, 1983